Attention! Information is for reference only!
Before taking the course, consult a doctor!
WEB SITE ONLY DIRECTORY. NOT PHARMACY! We do not sell medicines! None!

Description of the medicine: Roncoleukinum (Roncoleukinum)

Roncoleukinum.

Recombinant analog of endogenous human interleukin-2.

Stimulates the growth, differentiation and proliferation of T- and B-lymphocytes, monocytes, macrophages, oligodendroglial cells and epidermal cells of Langerhans.

Applied for the treatment of septic states of various etiologies in adults accompanied by immunosuppression, and as an antitumor agent in kidney cancer.

Assign intravenously (drip) at doses of 0.00025 g (0.25 mg) to 0.002 g (2 mg) 1 time per day; When septic conditions are administered 2-3 times to 0.0005-0.001 g (0.5-1 mg) with a break of 2-3 days; In kidney cancer, 5 infusions are carried out to 0.001-0.002 g (1-2 mg) with a break of 2-3 days, the courses are repeated after 1-2 months.

With the introduction of the drug, there may be an increase in body temperature.

Roncoleukin is contraindicated in allergic reactions to cytokines and yeasts, with autoimmune diseases, decompensated diseases of the cardiovascular system and during pregnancy.

Form release: lyophilized powder for injection solutions of 0.00025; 0.0005 and 0.001 g (0.25, 0.5 and 1 mg) (N. 5).